Lupin, one of the leading pharmaceutical companies in India, witnessed a sharp fall in share price on Thursday after it reported a marginal fall of 1.08% in consolidated net profit for the quarter ended Mar. 31, 2015.

ICICICdirect said the company's fourth quarter numbers were below I-direct expectations on the revenue, EBITDA as well as net profit fronts.

During the quarter net profit stood at Rs 5.47 billion for the quarter ended Mar. 31, 2015 as compared to Rs 5.53 billion in the same period last year. The company saw a decline of 1.36% in net revenues to Rs 30.78 billion from Rs 31.21 billion in the same quarter last year.

Shares of Lupin are trading at Rs 1,599.50, down Rs 91.1, or 5.39% at the Bombay Stock Exchange (BSE) on Thursday at 9:45 a.m.

Total volume of shares traded on the bourses today was lower by 26.97% to 842,091 compared with 22-day average volume of 1,153,031.